HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic relevance of urokinase type plasminogen activator, its receptor and inhibitors in chondrosarcoma.

Abstract
The plasminogen activation system plays an important role in enhancing pericellular proteolysis of tumor invasion/metastasis and in autocrine/paracrine tumor growth stimulation. To investigate the prognostic significance of the plasminogen activation system in human chondrosarcoma, the immunohistochemical expression of urokinase-type plasminogen activator (uPA), urokinase-type plasminogen activator receptor (uPAR), plasminogen activator inhibitor, 1 (PAI-1) and 2 (PAI-2) were analyzed in 28 patients with chondrosarcoma. In multivariate survival analysis, histological grade (p = 0.0008) and location (p = 0.02) were independent risk factors for local relapse. For metastasis-free survival, uPA index (p = 0.006) and PAI-2 index (p = 0.04) were independent prognostic factors. PAI-2 index (p = 0.02), uPAR index (p = 0.02) and histological grade (p = 0.03) predicted total survival. These results demonstrated the usefulness of uPA, uPAR and PAI-2 expression as biological prognostic indicator and the importance of the plasminogen activation system in tumor progression and metastasis in chondrosarcoma.
AuthorsT Morii, H Yabe, H Morioka, R Yamada, T Nakagawa, Y Toyama
JournalAnticancer research (Anticancer Res) 2000 Sep-Oct Vol. 20 Issue 5A Pg. 3031-6 ISSN: 0250-7005 [Print] Greece
PMID11062719 (Publication Type: Journal Article)
Chemical References
  • PLAUR protein, human
  • Plasminogen Activator Inhibitor 1
  • Plasminogen Activator Inhibitor 2
  • Receptors, Cell Surface
  • Receptors, Urokinase Plasminogen Activator
  • Urokinase-Type Plasminogen Activator
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Bone Neoplasms (classification, diagnosis, metabolism, pathology)
  • Chondrosarcoma (classification, diagnosis, metabolism, pathology)
  • Female
  • Humans
  • Immunohistochemistry (methods)
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 (metabolism)
  • Plasminogen Activator Inhibitor 2 (metabolism)
  • Prognosis
  • Receptors, Cell Surface (metabolism)
  • Receptors, Urokinase Plasminogen Activator
  • Urokinase-Type Plasminogen Activator (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: